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Endograft treatment of ruptured abdominal aortic
aneurysms using the Talent aortouniiliac system:
An international multicenter study
Noud Peppelenbosch, MD,a Robert H. Geelkerken, MD, PhD,b Chee Soong, MD, FRCS,c
Piergiorgio Cao, MD, FRCS,d Oren K. Steinmetz, MD,e Joep A. W. Teijink, MD, PhD,f
Mauri Lepäntalo, MD, PhD,g Jan De Letter, MD, PhD,h Frank E. G. Vermassen, MD, PhD,i
Guy DeRose, MD, FRCSS, FACS,j Erik Buskens, MD, PhD,k and Jaap Buth, MD, PhD, FRCS,a Eindhoven
and Enschede, The Netherlands; Belfast, Northern Ireland; Perugia, Italy; Montreal, Quebec, Canada; Heerlen, The
Netherlands; Helsinki, Finland; Brugge and Gent, Belgium; London, Ontario, Canada; Utrecht, The Netherlands
Objective: To understand the potential of endovascular aneurysm repair (EVAR) in patients presenting with a ruptured
abdominal aortic aneurysm (rAAA), the proportion in whom this procedure was applicable was assessed. Mortality and
morbidity was also determined in patients treated with emergency EVAR (eEVAR) when anatomic and hemodynamic
conditions allowed (ie, in the entire cohort with patients receiving endovascular and open repair combined). In addition,
a comparison was made between the treatment group with eEVAR and open repair.
Methods: Between February 2003 and September 2004, 10 participating institutions enrolled a representative sample
of 100 consecutive patients in whom eEVAR was considered. Patients in the New Endograft treatment in Ruptured
abdominal aortic Aneurysm (ERA) trial were offered eEVAR or open repair in accordance with their clinical
condition or anatomic configuration. Written informed consent was obtained from all patients or their legal
representatives. The study included patients who were treated by stent-graft technique or by open surgery in the case
of adverse anatomy for endoluminal stent-grafting or severe hemodynamic instability, or both. Data were collated
in a centralized database for analysis. The study was sponsored and supported by Medtronic, and eEVAR was
uniquely performed with a Talent aortouniiliac (AUI) system in all patients. Crude and adjusted 30-day or
in-hospital and 3-month mortality rates were assessed for the entire group as a whole and the EVAR and open repair
category separately. Complication rates were also assessed.
Results: Stent-graft repair was performed in 49 patients and open surgery in 51. No significant differences were
observed between these treatment groups with regard to comorbidity at presentation, hemodynamic instability, and the
proportion of patients who could be assessed by preoperative computed tomography scanning. Patients with eEVAR
more frequently demonstrated a suitable infrarenal neck for endovascular repair, a longer infrarenal neck, and suitable
iliac arteries for access than patients with open repair. The primary reason to perform open aneurysm repair was an
unfavorable configuration of the neck in 80% of the patients. In patients undergoing eEVAR, operative blood loss was
less, intensive care admission time was shorter, and the duration of mechanical ventilation was shorter (P < .02, all
comparisons). The 30-day or in-hospital mortality was 35% in the eEVAR category, 39% in patients with open repair, and
37% overall. There was no statistically significant difference between the treatment groups with regard to crude mortality
rates or rates adjusted for age, gender, hemodynamic shock, and pre-existent pulmonary disease. The cumulative 3-month
all-cause mortality was 40% in the eEVAR group and 42% in the open repair group (no significant differences at crude and
adjusted comparisons). The 3-month primary complication rate in the two treatment groups was similar at 59%.
Conclusions: In approximately half the rAAA patients, eEVAR appeared viable. An unsuitable infrarenal neck was the
most frequent cause to select open repair. In dedicated centers using a Talent AUI system, eEVAR appeared to be a
feasible method for treatment of a rAAA. The overall first-month mortality did not differ across treatment groups
(patients with endovascular and open repair combined), yet was somewhat lower than observed in a recent meta-analysis
reporting on open repair. ( J Vasc Surg 2006;43:1111-22.)Abdominal aortic aneurysms (AAAs) 5.5 cm in
diameter have a significant risk of rupture, which again
increases substantially when the aneurysm diameter is6.5
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(rAAAs) has typically been associated with an average in-
hospital mortality of 50%3-7 and only a modest improve-
ment in the outcome of rAAA repair was documented in a
recent meta-analysis in which the average mortality rate
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cular abdominal aortic aneurysm repair (EVAR) of elective
patients has been demonstrated to be associated with lower
30-day mortality and morbidity rates than open repair.9,10
Meanwhile, the use of emergency EVAR (eEVAR), as
assessed in a number of studies,11-25 has been associated
with a mean first-month mortality rate of 18.4% (range, 0%
to 45%). The improved outcomes in these reports may
reflect selective patient recruitment, however, with patients
selected for eEVAR constituting a lower-risk category be-
cause they would need to be stable for preoperative imag-
ing and have a suitable anatomic configuration for EVAR.
Thus, the favorable outcomes observed in the previous
studies may simply reflect selection bias.
Several questions regarding the use of eEVAR in rAAAs
remain. Among these uncertainties, the applicability rate
for eEVAR is a key factor. In particular, the anatomy of the
infrarenal neck and the patency of the iliac arteries may
preclude successful endovascular repair. Additionally, pri-
mary outcome events that need to be addressed include the
mortality rate of eEVAR in all patients who are candidates
for endovascular treatment and the effect of a preferential
eEVAR policy on mortality in an unselected group of
patients with rAAA. Furthermore, the infrastructural re-
quirements, such as the availability of rapid preoperative
imaging and around the clock surgeons experienced in
emergency endovascular aneurysm repair, need to be as-
sessed.
The present observational study, which is designated
the New ERA (Endograft treatment in Ruptured abdomi-
nal aortic Aneurysm) trial, was designed to overcome selec-
tion bias for an optimal assessment of eEVAR in the treat-
ment of rAAA. This report describes an international
multicenter cohort study of patients with rAAA who were
treated preferentially by eEVAR using a Talent aortouni-
iliac (AUI) stent-graft (Medtronic, Santa Rosa, Calif). The
outcome in the entire study group was assessed to allow a
comparison with mortality rates in patients treated by con-
ventional open surgery as reported in the literature. Addi-
tionally, the results observed in the eEVAR group were
compared with those in the open repair group.
METHODS
The New ERA study is a prospective, multicenter Eu-
ropean and Canadian study that is sponsored and sup-
ported by Medtronic and the Bakken Research Centre
(Maastricht, the Netherlands). Ten centers participated in
the study. Each participating clinical site had obtained
approval of the protocol from the local ethics committee.
Vascular surgeons and interventional radiologists with con-
siderable experience in the diagnosis and open and endo-
vascular treatment of rAAA were included as investigators
in this study. A list of participating investigators is in the
Appendix (online only). Patient data and procedural details
were recorded in a structured case report form (CRF) and
periodically monitored on-site by representatives of the
organizing company. All adverse events, including device-
and procedure-related events, and death were reviewed byan independent Adverse Event Advisory Committee (Ap-
pendix, online only). Study conduct was supervised by a
Steering Committee (Appendix, online only). The first
author and the principal investigator had access to all CRFs
at the end of the study period. The evaluation of the study
objective required 100 patients, each with a follow-up of 3
months. Enrollment into the study started in February
2003 and ended in September 2004.
The protocol specified that in each of the participating
centers, a consecutive series of patients treated for ruptured
infrarenal AAAs, who had given their informed consent,
were expected to be included in the study. The preferential
treatment was EVAR. The protocol recommended that
open surgery was only to be selected as the treatment when
anatomic criteria precluded effective exclusion of the aneu-
rysm or if the patient was in profound hypovolemic shock
(see the definition of severe hemodynamic instability below)
that did not allow a preoperative computed tomography
(CT) examination, fluoroscopy, or the use of intravascular
ultrasound (in one of the institutions) to evaluate feasibility
for EVAR. In other words, included in the study were
patients treated by stent-graft technique or by open surgery
in the case of adverse anatomy for endoluminal stent-
grafting or severe hemodynamic instability.
Patients who were suitable for EVAR were treated with
a uniform technique and a single endovascular device, the
Talent AUI stent-graft system (Fig 1) combined with a
femorofemoral bypass. The number and outcome of the
Fig 1. The components of the Talent aortouniiliac stent-graft
system used for emergency endovascular aneurysm repair.treatment of patients who did not give their informed
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cause the surgeon did not ask them to participate, and the
reasons for exclusion, were obtained from each of the
participating institutions by a questionnaire at the end of
the study.
Purpose and objectives. The New ERA study had
three main purposes. The first was to assess the proportion
of patients presenting with rAAA in whom EVAR by the
Talent AUI device could be used. The second was to
determine the operative mortality and morbidity in a co-
hort of patients treated with eEVARwhen possible, accord-
ing to present anatomic and hemodynamic criteria. This
analysis comprised the entire study group with patients
who underwent endovascular or open surgery. Finally, the
mortality and morbidity in the eEVAR and open repair
groups was compared. Study end points included operative
mortality, defined as death 30 days or during the same
hospitalization, and major morbidity, defined as serious
adverse events. Secondary end points included death from
all causes and major morbidity 3 months after the proce-
dure.
Patient selection, inclusion, exclusion criteria, and
management. Details of the inclusion and exclusion crite-
ria, management of the patient, and the technical execution
of the eEVAR by implanting the Talent AUI device were
described previously in an article on the design and plan-
ning of this study.26 Each participating center was expected
to enroll its series of patients with rAAA that met the
inclusion criteria consecutively throughout the study pe-
riod.
Briefly, the protocol required that on arrival in the
emergency department, intravenous fluid infusion wasmin-
imized, and if necessary, medication to lower blood pres-
sure was administered. If the hemodynamic situation al-
lowed an emergency CT examination, this was performed.
Aneurysm rupture was defined as hemorrhage outside the
aortic wall or by direct observation in case of laparotomy.
By protocol, when there was still doubt after treatment
whether the aneurysm was ruptured, extravasation was to
be confirmed by postoperative CT examination or by au-
topsy. The patient or his or her relatives were informed
about the study and asked permission to participate by a
written informed consent. The main exclusion criteria for
enrollment in the study were not consenting to participate
and comorbidities with a life expectancy of 1 year. Thus,
the study group consisted only of patients who met the
inclusion criteria and had signed (or their relatives or legal
representative) the informed consent.
An urgent CT examination was done in patients in
stable hemodynamic condition or with moderate hemody-
namic instability, referred to in this analysis when the
patient had a systolic blood pressure between 60 and 100
mm Hg, was conscious, and had no episodes of cardiac
arrest. The selection of patients for CT examination and
subsequently for EVAR or open repair was according to the
algorithm represented in Fig 2. This flow sheet dictated the
decisions to be taken at initial management, although it was
left to the discretion of the participating surgeon to deviatefrom these suggested guidelines. The algorithm advised
that severely hemodynamically unstable patients with a sys-
tolic blood pressure of 60 mm Hg, decreased conscious-
ness, or with episodes of cardiac arrest, should be taken to
the operating room and, if possible, undergo fluoroscopic
assessment to establish whether an EVAR or open surgical
procedure should be performed. The use of intra-aortic
balloon inflation to increase a low blood pressure was again
left to the discretion of the attending surgeon.
The suggested anatomic criteria for treatment by open
surgery included an infrarenal aortic neck of 10 mm or a
diameter of 32 mm, or both. In addition, an angulation
of the infrarenal neck of85° was considered an exclusion
criterion for EVAR, as were bilateral iliac artery occlusions
or stenosis (6 mm diameter) not amenable to balloon
angioplasty.
After CT examination, patients were quickly trans-
ported to the operating room for the selected emergency
procedure. In endovascularly treated patients, the preferred
operative technique in rAAA was an AUI stent-graft im-
plantation. The reasons for this preference, which is shared
with several other groups, include a larger application rate
of the stent-graft technique because of less anatomic re-
strictions and a quicker decompression of the bleeding
aneurysm.14,16,21,22 AUI endografting was combined with
a crossover bypass and the deployment of an Occluder cuff
in the contralateral iliac artery. The standard emergency set
of AUI stent-grafts and distal extender iliac device limbs
(Talent®, Medtronic, Santa Rosa, CA) represented in Fig 1
was permanently available in the ten centers.
It was recommended that eEVAR be commenced un-
der local anesthesia of the groin at the selected access site.
The rational for using local anesthesia in the initial part of
the procedure has been described previously by our group
and by others.26,27 The general idea is to avoid a severe
circulatory collapse associated with the induction of general
anesthesia in the patient with extensive retroperitoneal
blood loss because of vasomotor relaxation.28 In addition,
the loss of abdominal tone, which increases the risk of a
contained rupture becoming an intra-abdominal hemor-
rhage, is minimized by the use of local anesthesia.
After the AUI device was inserted and the antegrade
flow into the ruptured aneurysmal sac was blocked, general
anesthesia could be given to perform the subsequent oper-
ative steps, which consisted of exploration of the contralat-
eral common femoral artery, deployment of the common
iliac Occluder cuff at this side, and performing the cross-
over femorofemoral bypass. Also with regard to the tech-
nical execution of the procedure, the managing team could
deviate from any of the suggested steps except implantation
of the Talent AUI device when the patient was treated by
endovascular technique.
Statistical analysis. A priori, the applicability of the
endovascular technique was considered unsatisfactory if it
would be 50% of the patients. The intention was to
demonstrate that the mortality rate of consecutively en-
rolled patients with rAAA, treated by preferential EVAR,
would be 50%. As for secondary study end points, a
eratin
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groups was powered to demonstrate a statistically signifi-
cant 30-day or in-hospital mortality of25% in the patients
that had received eEVAR compared with 50% in the open
repair group.
Crude and adjusted hazard ratios with the 95% confi-
dence intervals (CI) and P values were assessed for differ-
ences in mortality rates in the subgroups. The factors for
which adjustment was made included advanced age, male
gender, hemodynamic shock (systolic tension 100 mm
Hg), and a history of pulmonary disease. These factors were
previously observed to influence outcome in patients un-
dergoing rAAA repair.3,5
The data processing and analysis were performed by the
first author and the principal investigator, with the techni-
cal assistance of Medtronic. A statistician (E. B.) reviewed
the manuscript and the validity of the conclusions. Results
were reported as means, standard deviation, or ranges.
Differences in findings between treatment groups were
assessed by 2 or Fisher exact tests for discrete variables and
by Mann-Whitney tests for continuous variables. Selected
variables were entered in a multivariate regression analysis,
and a Cox analysis was used to assess independent associa-
tions with the 3-month mortality rate. Only moderate or
severe adverse postoperative events29,30 were taken into
Fig 2. Flow sheet for patients with ruptured abdomina
with stable hemodynamic condition (systolic blood pre
instability (systolic blood pressure, 60 to 100mmHgwith
(CT) examination was to be performed. Patients with sev
Hg, with arrhythmia) were immediately taken to the opaccount. Per patient, the initial or most severe complica-tion, or both, was considered for the analysis. All analyses
were performed by SAS 9.1 statistical software (SAS Insti-
tute, Inc, Cary, NC).
RESULTS
Between February 2003 and September 2004, 100
patients (83 men and 17 women) with a mean age of 74
years (range, 58 to 90) were enrolled in the study. The
number of study patients from different centers varied
between 2 and 23 (mean, 10 patients) (see the Appendix
[online only] for the number of patients from each center).
Forty-nine patients underwent eEVAR, and 51 had opera-
tive repair. Table I summarizes the baseline characteristics
of the patients in the two treatment groups. Hemodynamic
instability at presentation was observed in 43 patients
(43%), and the mean systolic blood pressure was 100 mm
Hg (range, 0 to 200 mm Hg). There were no differences
between the treatment groups with regard to any of the
assessed preoperative variables, including the presence and
severity of hemodynamic instability.
Preoperative use of an occluding aortic balloon to
prevent severe hemodynamic collapse was needed in seven
patients: three in the eEVAR group and four in the open
repair group. The median time from admission to the
procedure was 90 minutes (range, 10 to 3060) for the
tic aneurysms (AAA) entering the hospital. In patients
of 100 mm Hg) and with moderate hemodynamic
ardiac arrhythmia), preoperative computed tomography
modynamic instability (systolic blood pressure60mm
g room. EVAR, Endovascular aneurysm repair.l aor
ssure
out c
ere heendovascular group and 60minutes (range, 12 to 1440) for
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significant. Preoperative CT examination was performed in
87 patients (87%) (Table II). In seven patients (7%), an
ultrasound examination revealed a rAAA, but the patients
were severely hemodynamically unstable and the surgeon
elected not to perform CT scanning. These patients were
directly transported to the operating room, where six un-
derwent open repair and the seventh underwent fluoro-
scopic assessment followed by endovascular repair. In five
patients (5%), all in one institution, intravascular ultra-
sonography (IVUS) was performed. In this center, it was
the policy that IVUS was used instead of preoperative CT
examination. One patient (1%) was reported to have had
a magnetic resonance angiography to assess the vascular
Table I. Baseline characteristics of patients presenting
with ruptured abdominal aortic aneurysm treated by











Male/female 42/7 41/10 83/17
Age  SD (years) 75.1  7.1 73.8  7.9 74.4  7.5
History (% of group)
Cardiac 9 (18) 8 (16) 17 (17)
Pulmonary 14 (29) 13 (25) 27 (27)
Renal 7 (14) 11 (22) 18 (18)
Carotid 4 (9) 12 (24) 16 (16)
Details at admission
Abdominal pain 45 (92) 45 (88) 90 (90)
Collapse of patients 27 (55) 26 (51) 53 (53)
Hemodynamic
instability 21 (43) 22 (43) 43 (43)
Moderate* 16 (33) 19 (37) 35 (35)
Severe† 5 (10) 3 (6) 8 (8)
Lowest systolic BP
mean  SD in
mm Hg 100  41 101  42 101  42
eEVAR, Emergency endovascular aneurysm repair; BP, blood pressure.
Figures indicate number of patients (%) unless indicated otherwise.
*Systolic blood pressure, 60 to 100 mm Hg.
†Systolic blood pressure 60 mm Hg.
Table II. Preoperative imaging
eEVAR
(n  49) (%)
Open repair
(n  51) (%)
All patients
(n  100) (%)
US 1 (2)* 6 (12) 7 (7)
CT scanning (with/
without US) 43 (88) 44 (86) 87 (87)
IVUS 5 (10) — 5 (5)
MRA — 1 (2) 1 (1)
eEVAR, Emergency endovascular aneurysm repair; US, ultrasound; CT,
computed tomography; IVUS, intravascular ultrasound; MRA, magnetic
resonance angiography.
*This patient had a preoperative US study and later underwent intraopera-
tive fluoroscopy and endovascular repair.anatomy.Forty-nine patients had a suitable anatomy and were
treated with eEVAR (Table III) for an overall applicability
rate for eEVAR of 49%. Three additional patients, accord-
ing to their CT findings in retrospect, appeared suitable for
eEVAR. At the time of admission, however, unavailability
of experienced endovascular staff (in two) or severe hemo-
dynamic instability (in one) precluded eEVAR. Taking
these cases into account, at least 52% of the study cohort
had a vascular morphology that would have allowed an
EVAR procedure.
The principal reason to perform an open aneurysm
repair was an adverse configuration of the neck in 40
patients: the neck was too short in 34 patients, too angu-
lated in two, and the diameter too wide for available devices
in four. It should be noted that accepted criteria for neck
length in EVAR were not followed rigorously, as endovas-
cular repair was performed in five patients with a neck10
mm. Other adverse anatomic factors included small diam-
eter or occluded iliac arteries in two patients and iliac
arteries that were too angulated in 14 patients. Moreover,
moderate or severe hemodynamic instability precluded
EVAR in seven patients (14%).
At statistical comparison, a number of anatomic char-
acteristics were different in the treatment groups. Patients
with eEVAR more frequently demonstrated an infrarenal
neck suitable for EVAR and longer necks (Table III). No
significant differences were observed in aneurysm diam-
eter, neck diameter, angulation of the neck, iliac arteries
suitable for EVAR, and angulation of iliac arteries. This
comparison did not include patients with open repair who
were not examined by CT because of severe hemodynamic
instability.
The procedure and early course. The anesthetic
technique involved general anesthesia in all patients with
open repair compared with 33 patients with eEVAR (P 
.05). In this latter category, 21 patients had local anesthesia
during the initial part of the procedure and general anes-












(%)‡ 49 (100)‡ 11 (25)‡ 60 (65)
Proximal neck length (mm)§ 21  12§ 9  12§ 16  13
Proximal neck diameter
(mm) 25  3 25  8 25  6
Iliac arteries suitable (%) 47 (96) 35 (80) 82 (88)
Aneurysm diameter (mm) 75  16 80  15 78  15
eEVAR, Emergency endovascular aneurysm repair.
Data are given in numbers (%) or mean  SD.
*Either computed tomography examination, magnetic resonance angiogra-
phy, intravascular ultrasound or ultrasound scan followed by fluoroscopy.
†More than one factor per patient was possible.
‡P  .0001.
§P  .0001.thesia after deployment of the AUI device, whereas re-
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patients. Twelve patients had general anesthesia for the
entire procedure. Procedural details for each of the two
treatment modalities are shown in Tables IV and V. Supra-
renal control by clamping during the procedure in patients
with open repair was significantly more frequent than su-
prarenal balloon occlusion in patients with eEVAR (P 
.001). The volume of replaced blood was less in the eEVAR
group (P .001). A primary conversion to open repair was
required in three eEVAR patients (6%) because of device
migration that caused a persistent type III endoleak in two
and because the device could not be advanced as a result of
too narrow iliac arteries in one. The distal landing zone in
the other 46 patients with endovascular repair was in the
common iliac artery in 36 and in the external iliac artery in
10 patients. Endoleaks at completion angiography were
Table IV. Operative details in patients with emergency
endovascular aneurysm repair
eEVAR
(n  49) (%)
Use of supra-renal balloon 3 (6)*
Deployment success 45 (92)
Conversion to open repair 3 (6)
Fluoroscopic time, mean  SD (min) 19  9
Postoperative completion angiogram endoleak 11 (22)
Type I proximal 3
Type I distal 4
Type II 4
Type III —
Operation time (min) 173  60
Replaced blood volume (mL)† 1322  1494†
I.C.U. stay (days)‡ 5.8  9.4‡
Mechanical ventilation (hours)§ 71  159§
Hospital stay (days) 14.9  16.4
eEVAR, Emergency endovascular aneurysm repair.
Data are given in numbers (%) or mean  SD.
*P  .001 compared with suprarenal clamping in open repair Table V.
†P  .001 compared with open repair Table V.
‡P  .019 compared with open repair Table V.
§P  .001 compared with open repair Table V.
Table V. Operative details in patients with open repair
Open repair (n  51)
Suprarenal clamping 22 (43%)*
Aortic cross-clamp time (min) 56  27
Tube graft/bifurcated graft used 35/16
Operation time (min) 177  54
Replaced blood volume (mL)† 2411  2159†
ICU stay (days)‡ 9.4  14.6‡
Mechanical ventilation (hours)§ 165  317§
Hospital stay (days) 22.2  28.2
ICU, Intensive care unit.
Data are given as numbers (%) or mean  SD.
*P  .001 compared with eEVAR Table IV.
†P  .001 compared with eEVAR Table IV.
‡P  .019 compared with eEVAR Table IV.
§P  .001 compared with open repair Table V.identified and accepted in 11 patients (22%).No group differences were observed with regard to the
duration of the procedure; however, the intensive care unit
stay was significantly shorter in the eEVAR group than in
the open repair group (Tables IV and V). The same was
true for time on the ventilator. There was no statistically
significant difference in hospital stay between the groups.
Mortality. The overall 30-day or in-hospital mortality
was 37 (37%) for the entire study group; 17 (35%) died in
the eEVAR group and 20 (39%) in the open repair group.
There was no statistically significant difference between the
type of operation and crude or adjusted mortality rates
(Table VI).
The all-cause mortality at 3 months was 40% in patients
with eEVAR and 42% in the open repair category (differ-
ence not statistically significant) (Fig 3). The adjusted
3-month mortality was not different for the treatment
groups (Table VI). Independent associations were found
between hemodynamic shock at admission (systolic blood
pressure  90 mm Hg) and a history of pulmonary disease
and mortality. The causes of death are listed in Table VII
and included hemorrhage, cardiac arrest, respiratory insuf-
ficiency, and multiorgan failure as the most frequent causes
of death. No statistically significant differences were found
between the participating centers and the overall mortality.
Complications. The primary postoperative complica-
tions in 24-hour survivors and reinterventions that oc-
curred30 days and from 1 to 3months are summarized in
Table VIII. There was no difference with regard to the
overall number of complications or the different types of
complications between the treatment groups. Of the 85
24-hour survivors, 50 patients (59%) experienced one or
more complications: 24 patients (59%) in the eEVAR
group and 26 patients (59%) in the open repair group.
Reinterventions by laparotomy in the eEVAR group in-
cluded a banding at the infrarenal neck 4 days postopera-
tively for a type I endoleak that had caused a secondary
rupture. In another patient, a secondary conversion to open
repair findings after the procedure was performed because
of a type I proximal endoleak. Notably, paraplegia devel-
oped in four patients (4%), two in each treatment group.
Excluded patients. During the study period, 134 pa-
tients were not enrolled in the study (data obtained by
questionnaire). The number of patients excluded from each
participating center ranged from 2 to 39, and the propor-
tion of excluded patients ranged from 12% to 94%. Four
centers were responsible for 113 (84%) of all patients not
enrolled. The reasons that patients were not enrolled in-
cluded informed consent not obtained or asked for, endo-
vascular team unavailable, suprarenal aneurysm (which was
in fact an exclusion criteria for this study), severe hemody-
namic instability (which condition would have allowed
inclusion with the option of allocating the patient to im-
mediate open repair), and the use of a bifurcated stent-graft
system of a different brand (one patient). Frequently, more
than one reason was reported. The mean perioperative
mortality in the patients excluded was 41%.
90 m
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Although an immense increase in the expertise with
EVAR in elective cases was observed during the last decade,
only a limited number of centers have thus far published
their experience with EVAR in rAAAs.11-27 The present
study was organized in cooperation with Medtronic. It was
intended to systematically assess the outcome of treatment
in a consecutive patient cohort undergoing either endovas-
cular or open repair. This design, which differed from





30-day or in-hospital mortality† 17 (35%) 20
3-month all cause mortality†‡ 20 (40%) 22
eEVAR, Emergency endovascular aneurysm repair; CI, Confidence interval
*Odds ratios (OR) and hazard ratios (HR) from multivariate regression mo
†Adjusted for operation type, age, gender, shock (systolic blood pressure 
‡Adjusted for follow-up time (see Fig 3).
Fig 3. Kaplan-Meier survival curve for emergency endo
patients.previous studies on emergency use of EVAR, was chosen toevaluate the following aspects: the applicability rate or the
proportion of patients with anatomy that would allow
endovascular repair, the overall perioperativemortality rate,
and the mortality and morbidity rates in the endovascular
and open repair groups separately. The study was organized
as multicenter project to assess emergency rAAA repair
using endovascular techniques where applicable. A broad
range of institutions participated to accumulate a suffi-
ciently large cohort in a short period, to realistically reflect
neurysm repair and open repair
ir
OR and HR; 95% CI, P value* adjusted†
operation type 1.14 (0.46-2.80; P  .78)
age 1.05 (0.98-1.12; P  .19)
gender 1.91 (0.55-6.64; P  .31)
shock 3.85 (1.57-9.47; P  .003)
Hx pulmonary 1.41 (1.00-1.97; P  .05)
operation type 1.20 (0.65-2.24; P  .56)
age 1.02 (0.98-1.08; P  .35)
gender 1.51 (0.66-3.46; P  .33)
shock 2.69 (1.52-5.58; P  .0013)
Hx pulmonary 2.22 (1.19-4.14; P  .0121)
m Hg ) and pulmonary history.






dels.vascucurrent practice, and to allow for generalization of our
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number of notable findings evolved from this effort.
The proportion of patients with anatomic dimensions
allowing endovascular repair reported in previous reports
varied from 28% to 83%.15,17,21,24,25 In the present study
group, half of the patients underwent eEVAR. Adverse
anatomy appeared to be the most frequent reason for
selecting open repair. Logistic factors such as unavailable
endovascular expertise precluded eEVAR in the study
group in only 6% (three patients) of the open repair group.
The potential effects of the relatively large number of
excluded patients (often also because of logistic factors) will
be considered at the end of this discussion.
Lower eligibility rates (23% to 37%) indicated in a
number of previous reports15,17,20-22 were probably asso-
ciated with more restrictive anatomic criteria than recom-
mended in our study protocol.26 Five patients in the EVAR
group (10%) had necks of 10 mm (our recommended
threshold), and another 11 patients (22%) had necks of
15 mm (often suggested as a contraindication for elective
EVAR). These observations signify that the anatomic crite-
ria for eEVAR were applied liberally in the present study.
Rigid application of generally recommended anatomic
guidelines, well justified in elective EVAR, seems counter-
productive in emergency treatment of rAAA. However, the
safety and efficacy of the expanded criteria remain to be
determined even though our outcomes appear generally
favorable.
A preoperative CT examination was performed in 87%
of the patients in an almost equal proportion of the two
treatment groups. Hemodynamic status (ie, severe or mod-
erate instability on average) was comparable in the two
treatment groups; however, hemodynamic instability pre-
cluded any other imaging than ultrasound scans in 12% in
the open repair group. In retrospect, our categorization
into moderate and severe hemodynamic instability, meant
to assist in decision-making, did not correlate with the
selected treatment. Apparently, the response to hemody-
namic shock varies from one surgeon to another. Some will







30-day or in-hospital total 17 (35%) 20 (39%) 37 (37%)
Hemorrhage 6 6 12
Cardiac 3 3 6
Pulmonary 3 4 7
Bowel 2 2 4
MOF* 3 4 7
Miscellaneous — 1 1
1- to 3-month total 3 (6%) 2 (4%) 5 (5%)
Cardiac — 1 1
Pulmonary 1 1 2
MOF* 1 — 1
Miscellaneous 1 — 1
eEVAR, Emergency endovascular aneurysm repair.
*Multiorgan failure (failure of  three organs).prefer open repair in a critical situation, whereas others willproceed with EVAR if the arterial morphology allows. In
the eEVAR-group, 10% underwent preoperative IVUS (all
in one center) instead of CT examination. In only one
patient, the alternative pathway of triage between eEVAR
or open repair by fluoroscopic arteriography immediately
before the intervention was used. Thus, a CT examination
is possible in almost all patients with rAAA. This is in
agreement with the findings of Lloyd et al,31 who observed
that of patients who did not undergo repair of their aneu-
rysm, 87.5% survived for more than 2 hours after admission
in hospital.
The Talent AUI stent-graft was adopted as the single
endovascular device in this study to reduce a large variation
in operative technique and device characteristics. The use of
an AUI stent-graft reduces intra-aneurysm sac pressure
more effectively than bifurcated devices, as was confirmed
in model study by Gawenda et al.32 This advantage is
greatest in unstable patients. Moreover, in patients with
elective EVAR, AUI devices increased the proportion of
patients treatable by endovascular technique by 19% to 45%
because an unilateral access problem did not preclude the
endovascular repair.33,34 This aspect applies also to rup-
tured aneurysms. An additional advantage is the shorter
learning curve with AUI stent-grafts compared with bifur-
cated stent-grafts, which may increase the number of cen-
ters that can perform eEVAR in rAAA.35
The use of a femorofemoral prosthetic bypass is con-
sidered a disadvantage by some. Potential risks include late
occlusion or infection of the prosthetic bypass.36 In the
present study, only one patient had a prosthetic infection,
which was successfully treated by replacing the crossover
bypass by a vein graft. In an overview of the literature, it was
concluded that the complication rate of femorofemoral
bypasses in combination with AUI devices was low, and the
long-term patency was excellent.36-38
Of 24-hours survivors, 59% had moderate or severe
postoperative complication (Table VIII). Others have re-
ported a comparable high figure,23 but in other series this
rate was lower (22% to 46%).14,16,17,24 A likely explanation
for the higher major morbidity is that the present study was
prospective, which usually accounts for a higher reported
rate of complications. Similar to most reports on open and
endovascular repair, multiorgan failure, limb ischemia re-
quiring thrombectomy, and cardiac and respiratory events
were frequent complications in both treatment groups.
Although we anticipated that eEVAR might be associated
with fewer complications than open repair, the incidences
in both groups were similar. The 4% rate of paraplegia was
surprising. An assessment of the pathogenesis and risk
factors of this complication after eEVAR was recently pub-
lished by some of the present authors.39
The 30-day mortality in the present trial was consider-
ably higher compared with some published single institu-
tion series in which this rate in eEVAR patients was 8% to
14%.18,22-24 There may be several explanations for this
difference:
First, selection bias seems a reasonable explanation of
the seemingly favorable results observed in previous stud-
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endovascular treatment, and the outcome in patients with
open surgery for their ruptured aneurysms in the same
period was not reported.
Second, the presence of severe or multiple comorbidi-
ties may cause different outcomes between series. Notably,
medical eligibility for open repair was not a prerequisite for
enrolment in the present study, which may have resulted in
the acceptance of patients with quite severe comorbidities
for endovascular repair.
Third, hemodynamic status is strongly associated with
the overall outcome. In a recent series by Hechelhammer
et al,24 only 22% of their patients were in hemodynamic
shock preoperatively, as opposed to twice as many (43%) in
the present study (systolic blood pressure of100 mmHg
in both studies).
The higher percentage of patients treated by endovas-
cular repair in combination with less favorable prognostic
factors (confounders), compared with most of the previ-
ously reported series, may very well explain the higher
mortality in the present study. Nevertheless, the 35% mor-
tality rate in the eEVAR group and the 37%mortality in the
study group overall still compare favorably with the often-
observed 40% to 50% perioperative mortality in open repair
series.
One may consider that essentially three types of pa-
tients with rAAA will present for treatment. The first cate-
gory includes the patient who will not survive the first
postoperative month irrespective of whether the operation
is by endovascular or by open surgical technique. Death in
this patient category appears unpredictable; no single pre-
existing risk factor can reliably indicate the expected clinical
course, as was assessed in earlier open repair series.3,5
Table VIII. Primary complications
30-day or in-hospital*
eEVAR (n  41) (%) Open repair
Cardiac 5 (12) 5 (
Pulmonary 2 (5) 4 (
Renal (with dialysis) 1 (2) 1 (
Bowel ischemia 2 (5) 3 (
Paraplegia 2 (5) 2 (
Reintervention (total) 3 (7) 3 (
Thrombectomy 1
Ffx infection‡ — —
Late conversion 1 —
Laparotomy 1




Data are number of patients and percentages (%), unless indicated otherwis
Patients are categorized to their most severe complication.
*Of 24-hour survivors.
†Of 30-day or in-hospital survivors.
‡Femorofemoral crossover bypass replaced by vein.
§Failure of  three organs.Patients in the second category may be assumed to surviveany type of repair. For these two categories, the introduc-
tion of EVAR will not be of decisive importance. At most,
the duration of the intensive care unit admission or the
number of days on the ventilator may be less with eEVAR.
Finally, a third category may be recognized. This group
consists of patients that will not tolerate the initial challenge
of a laparotomy, aortic clamping, lower-limb ischemia,
hypothermia, and systemic and coagulation disturbances.
This may be the patient who survives the perioperative
period because of the lesser challenge of the endovascular
procedure. How large this proportion of patients is cannot
be estimated at the present time.
The large number of patients who were excluded be-
cause no informed consent was obtained was disturbing
and, at first sight, appears to undermine the validity of this
study. In fact, 134 nonenrolled patients underwent open
repair, except one in whom implantation of a bifurcated
endograft from another company was performed. How-
ever, since informed consent was not obtained or asked for
(largely because the attending surgeon was inexperienced
in eEVAR) for most of the nonenrolled patients, selection
leading to a bias is not an issue. Not asking for informed
consent in an emergency situation or because personnel
requirements were not met may be considered a random
phenomenon with regard to patients being admitted for
rAAA, that is, it did not result in systematic inclusion of
patients with exceptionally good or poor prognosis. In fact,
this observation signifies the large organizational chal-
lenges even in dedicated centers with the endovascular
management of emergency cases.
The proportion of nonenrolled patients with an unsuit-
able anatomy for EVAR could not be examined because CT
examination was rarely performed. Still we have no reason
1- to 3-month period†
























e.to assume that the EVAR application rate is different from
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mortality was very much similar in patients enrolled under-
going open repair (39%) and nonenrolled (41%) patients,
virtually all of whom underwent open repair (P value of
2% difference with 95% CI). This again corroborates com-
parability between the enrolled and nonenrolled groups.
Thus, we believe that that our conclusions, which were
based on the patients enrolled, may still be generalizable to
the larger population of rAAA patients.
CONCLUSIONS
Questions that were answered in the present study
included that eEVAR appeared to be a feasible method for
most dedicated vascular centers to treat rAAA. Also, a good
outcome may be anticipated for most patients. The mortal-
ity after eEVAR was 35% and the overall mortality was 37%,
which compared favorably with most previously published
results of open repair.3-7 In the simultaneously nonenrolled
group, mortality was 41% after open repair. Half of the
patients with rAAA in our study were treated by endovas-
cular technique, which is higher than in most previous
studies.
The availability and number of endovascular teams with
experience in emergency endovascular repair needs to im-
prove to include most patients with a ruptured infrarenal
abdominal aneurysm in a preferential treatment by EVAR
protocol. In a well-organized setting, the advantages of less
blood loss, avoiding of laparotomy, and shorter time in the
intensive care unit and on mechanical ventilation should
translate into a further decrease of the perioperative mor-
tality.
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Mr Kevin Burnand (London, UK). I wonder whether you’d
tell us how many people were excluded from this study, because
that’s obviously a very important piece of information. Could you
tell us how many people died during the assessment period?
Finally, could you tell us whether there was any difference in
outcome between patients with a short neck, because one would
expect these patients to have a poorer outcome.
Dr Noud Peppelenbosch. With regard to the exclusion of
patients, we retrieved this information from the participating insti-
tutions by questionnaire at the end of the study period.
As many as 134 patients were excluded from this study. The
main cause for exclusion was no available patient consent, and the
second cause was no unavailable staff with endovascular experience
at the time of presentation at the hospital. Of those 134 patients, all
except one were treated with open repair. One patient received
endograft treatment with a bifurcated system of another company,
and this patient was excluded. The 30-day mortality in the ex-
cluded group was 41%.
Mr Burnand. So, could you give us a rough idea of howmany
people it would be appropriate for? My guess is 20% to 30%; is that
right?
Dr Peppelenbosch. I think the application rate remains 50%,
comparable with the rate in the included patients. We cannot be
certain about this estimate because the majority of excluded pa-
tients did not receive a CT examination. However, because the
primary reasons for exclusion from this study regarded logistic
factors (not anatomic), there is no indication that the proportion of
patients with anatomy feasible for endovascular repair will be
different than in the included category.
Dr Munier Nazzal (Toledo, Ohio). I have two questions.
The first one, you did not tell us about the surgical group, what
type of aneurysm (in relation to the renal artery)? I assume thatdifficult from the surgical point of view, with higher complication
rates. The second question is how do you explain the similarity in
hospital stay?
Dr Peppelenbosch. To start with your last question, it may
not be the treatment modality that determines the occurrence of
complications and the duration of the hospital admission. It is most
likely the disease itself. General patient characteristics, risk factors,
and hemodynamic situation were the same for patients with endo-
vascular and open repair. We did not present these data here, but
the morbidity figures in both treatment groups were similar. When
we consider the overall high morbidity rate in this cohort, an
operative (one-month) survival of over 60% can be considered
acceptable.
Dr Donald P. Spadone (St. Louis, Mo). Was abdominal
compartment syndrome a problem in ruptured aneurysm patients
treated with EVAR? How many patients required a secondary
procedure to treat abdominal compartment syndrome or other
problems with intra-abdominal thrombosis?
Dr Peppelenbosch. Approximately 12% of the patients re-
ceived a secondary intervention. The most frequent reinterven-
tions included thrombectomy and device extensions and other
procedures, such as coiling of side branches, to treat type I and II
endoleaks. Two patients had an abdominal compartment syn-
drome.
Dr John Hallett (Charleston, SC). Was there a difference in
time from the arrival and diagnosis to when treatment was com-
pleted for the two? First question. And second, is there a difference
in the cost and total cost of hospitalization between the two.
Dr Peppelenbosch. There was no difference in time period
from the arrival at the hospital until the operation. In both treat-
ment groups, it was approximately 1.5 hours. Most patients in the
open repair group received also a CT examination, explaining the
similar time interval until operation.
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presented our own single-institution experience of UAB at the
Peripheral Vascular Surgery Society. Our findings were similar to
yours, with similar survival in both groups, but our conclusions
were a little different. Specifically, we have taken the approach, if
the ruptured aneurysm arrives and the anatomy is suitable, we
prefer endografting because the endograft makes a relatively un-
stable or an emergency situation stable that can be converted later
if we need to. My real preference is to go with endovascular repair.
Ultimately then, my question is, can we really support or do you
really think we should push ahead with a randomization protocol?
I mean, we have a minimally invasive approach that can at least
stabilize the patient and has similar short-term outcome.
Dr Peppelenbosch. Our protocol included the option of the
use of an occluding aortic balloon, which was used in about 8% of
the reported patients preoperatively. In addition, the protocol
included taking severely unstable patients directly, without a CT
scan, to the operating room. When the condition permits, we can
use fluoroscopy for further triage. When CT or fluoroscopy is not
possible, an open repair is performed.
Dr Jordan. So you are demonstrating our same practice
pattern, but I am asking if you think we should do a randomization
protocol based upon what you—and it sounds like the practitio-
ners in your group—practice. Do we need to go and push for
randomization for this problem?
Dr K. Craig Kent (New York, NY). Dr Buth, do you want to
comment?
Dr Jaap Buth. We think that the present study is not the final
answer on what is the best approach. There is still equipoise on
what is the best treatment for a ruptured AAA. A randomized
comparative study with two treatment arms, the first preferential
EVAR and the second standard open surgery, seems a proper next
step to our present report. In this randomized trial, the preferential
EVAR group subsequently needs to be divided into two sub-
groups, one where EVAR can be performed on the basis of
anatomy and hemodynamic situation and the second subgroup
where anatomy is unfavorable and an open repair is required. In
our view, a randomized trial of this design will be the best way to
find out which treatment is best in patients with a ruptured AAA.
Dr Takao Ohki (Bronx, NY). We have been proponents of
this approach also, and we do have some experience. And from our
own experience, I can tell you that some patients were hurt by
insisting on endovascular repair in the presence of unfavorable
anatomy. Although you did select out some unfavorable anatomy
in terms of the length and the diameter of the proximal neck, you
didn’t take into account the tortuosity and other anatomic factors
that may make endovascular repair difficult. The selection process
in your trial most likely negatively impacted the mortality of the
open repair, because the unstable patients preferentially got the
open repair and the patients with more difficult anatomy got
the open repair. So the open repair suffered from the fact that they
were dealing with more challenging patients, yet there was no
difference in mortality. So there is a possibility that the endovas-
cular repair was, in fact, hurting the patients.
Have you done some analysis looking at outcome in compa-
rable groups of patients in terms of anatomy and hemodynamic
stability? I hate to say this, because I do believe endovascular repair
is the way to go, but there is a possibility that endovascular repair
may be harmful if used inappropriately.
Dr Peppelenbosch. We didn’t perform a separate comparison
for hemodynamically stable and unstable patients. We believe that
the endovascular technique is also feasible in the majority of
unstable patients. We observed that both patient groups were
comparable with regard to hemodynamic instability and general
risk factors, including cardiac disease, renal disease and pulmonary
disease. We have not expected this to be the case. An important
difference with previous published studies was that in our series
two-thirds of the patients were hemodynamically unstable. Inmost
other reports, approximately 20% was unstable. This difference inpatient selection explains a higher mortality in the present study
compared with previous studies.
Dr Kent.Tak, stay at the podium for a second. Your group has
published a number of articles suggesting that mortality can be
reduced fairly dramatically with endovascular repair, and now we are
hearing data that suggests the contrary. Since I have both of you at
opposite microphones, is there any way to reconcile this? Tak, what
do you think is the secret that you might have that Dr Peppelen-
bosch was not able to demonstrate in this multicenter trial?
Dr Ohki. Can I speak my mind?
Dr Kent. Oh, I’m afraid of the consequences, but let’s give it
a try.
Dr Ohki. Maybe better surgeons, better endografts. I think
our patients were equally unbiased in terms of the hemodynamic
instability since we treated all comers. One major difference in-
cludes the fact that we used the occlusion balloon more often than
you did. Also, we preferentially used the balloon-expandable stent,
which performs better in angulated and short necks than the
self-expanding-type device that you used. Finally, single-center
trials usually produce a better outcome than multicenter trials. I
think these are the major differences that I can come up with, short
of the fact that we were better surgeons.
Dr Kent. Dr Buth, why don’t you respond to this.
Dr Buth. The issue of which device is better is difficult to
prove. Obviously, there are subjective preferences here. Our view is
that the aortouniiliac device of Medtronic is quite suitable for the
treatment of ruptured abdominal aortic aneurysms. In this series,
many patients had shorter necks than usually would be considered,
eg, criteria were more liberal in the endovascular group than in an
elective EVAR group. In this regard, I may respond to one of the
previous discussants who asked whether the open repair cases in
this study were technically more difficult. We didn’t have that
impression from our data. We believe that the open repairs were
rather standard, without a frequent need for supraceliac clamping.
Also, the reimplantation rate of visceral arteries was low, with
approximately 5%. There was, however, an increased rate of supra-
renal clamping, which was approximately 40%, if compared to the
literature.
To come back to Tak Ohki’s comments. These re-emphasize
the need for a randomized study. Indeed, we may harm an indi-
vidual patient, but we don’t know how many. At present, the
mortality rates in our and other studies are lower than in classic
open repair series. Therefore, we feel confident that more patients
will benefit from the endovascular procedure. The only way to find
out is a sufficiently powered randomized study.
Dr Michael Golden (Philadelphia, Penn). You mentioned
that you had separated out the patients that were hemodynamically
unstable and they went to open repair, and also that about half, or
more than half, of the endovascular-treated group was actually
treated without general anesthesia. However, it appears that your
postoperative ventilatory support requirement was actually an ap-
preciable amount of time for EVAR patients also, as was the
hospital stay. Can you comment on the respiratory complications
of the EVAR group? Was it a small number of the EVAR patients
that had a high level of morbidity, with very long ventilatory
requirements, or was the respiratory morbidity relatively common
with EVAR patients, but of shorter duration?
Dr Peppelenbosch. The morbidity rates in the endovascular
and open repair groups were fairly similar. Statistically significant
differences were observed in the intensive care unit stay and the
time on mechanical ventilation in favor of the endovascular group.
In addition, probably related to time on the ventilator, pulmonary
complications were less frequent in patients with endovascular
treatment. However, the latter was not statistically significant.
Other complications that arose included renal failure, with two
patients who required dialysis. Cardiac problems occurred more in
the open repair group, but none were statistically significant, which
we found surprising. Perhaps the high proportion of patients with
hemodynamic instability explains why the morbidity rate was 26
independent of the type of treatment.
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Since the mortality rate for open repair of ruptured abdominal
aortic aneurysm (AAA) is 40% to 50%, vascular surgeons have felt
intuitively that it should be possible to improve on these results by
using the endovascular method of repair (EVAR). It has not, how-
ever, been easy to find objective evidence and statistical proof of the
superiority of EVAR in this situation. The impact of EVAR on
ruptured AAA has also been disappointing in terms of the number of
cases treated. Veith1 has reported 442 cases with a mortality of 20%
from an international survey conducted over a 5-year period. This
perhaps should not surprise us since Greenhalgh’s group2 have re-
ported that only 24 of 103 patients whose AAA ruptured during
ultrasound surveillance were able to be treated by operation. This
figure would, in all probability, be halved again if anatomical criteria
for endovascular repair were applied.
The report of Peppelenbosch et al3 of the first multicenter
study comprising 100 patients is therefore welcome. It should be
seen in the context of the obstacles in conducting such a study, not
least of which is the logistic difficulty in providing skilled endovas-
cular, radiology, anesthetic, and nursing teams around the clock.
Not withstanding this, however, the limitations of this study must
be considered.
One hundred patients were enrolled in the study, and 134
were excluded. There is much information on the 100 patients in
study group but very little on the 134 who were excluded, and
what information the authors have on this group is according to a
survey by questionnaire conducted at the end of the study. Not all
of the exclusion criteria are provided, but the main criteria are
stated to be “not consenting to participate in the study and
comorbidities with a life expectancy less than one year.” Addition-
ally, 14% of enrolled patients in the EVAR group were excluded
from EVAR because of moderate or severe hemodynamic instabil-ity and were transferred to the open group. Under these circum-
stances, despite reassurance by statisticians, the study group and
the subgroup treated by EVAR are highly selected. It is therefore
difficult to know what relevance the outcome of these two group-
ings has to the practical day-to-day management of patients pre-
senting with rupture to emergency departments.
The major finding of equality of survival between the group
treated by EVAR and that treated by open repair is difficult to
interpret. Since the EVAR group was favored by exclusion of 14%
of patients as a result of hemodynamic instability and the open
repair group was additionally disadvantaged by inclusion of pa-
tients with anatomically unfavorable or absent proximal necks, it is
difficult to understand why the outcome of the open group was so
good and that of the EVAR group was so comparatively bad.
The relationship of the investigators and device manufactur-
ers, although common practice, is not ideal. The study was spon-
sored and supported by the manufacturers and periodically moni-
tored on site by them. Data processing and analysis were performed
by the first author and principal investigator with the technical
assistance of the manufacturers.
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